| IVIG (n = 19) | Placebo (n = 19) | P-value |
---|---|---|---|
Admission reason | Number of patients | ||
Respiratory failure | 7 | 8 | 1.00 |
Cardiopulmonary resuscitation | 1 | 2 | 1.00 |
Sepsis/septic shock | 9 | 8 | 1.00 |
Cardiogenic shock | 1 | 1 | 1.00 |
Coma | 1 | 0 | 1.00 |
Age (years) | 61 ± 11 | 66 ± 12 | 0.18 |
Gender (female/male) | (7/12) | (10/9) | 0.52 |
BMI (kg/m2) | 28 ± 5 | 28 ± 6 | 0.94 |
SOFA score | 11 ± 4 | 11 ± 5 | 0.88 |
APACHE III score | 96 ± 28 | 96 ± 24 | 0.99 |
Mortality on Day 14 (non-survivors (%)) | 3 (16%) | 3 (16%) | 1.00 |
Mortality on Day 28 (non-survivors (%)) | 5 (26%) | 6 (32%) | 1.00 |
Length of ICU stay (days) | 30 ± 16 | 27 ± 13 | 0.66 |
CIP score on Day 0 | 2.6 ± 1.5 | 2.0 ± 1.3 | 0.26 |
CIM score on Day 0 | 1.1 ± 0.8 | 1.4 ± 0.8 | 0.27 |
CIPNM severity sum score on Day 0 | 3.6 ± 1.8 | 3.4 ± 1.5 | 0.71 |
C-reactive protein (mg/dL) on Day 0 | 13 ± 11 | 13 ± 8 | 0.99 |
Fibrinogen (mg/dL) on Day 0 | 462 ± 186 | 563 ± 192 | 0.11 |
Leukocytes (G/L) on Day 0 | 19.4 ± 10.3 | 18.6 ± 8.7 | 0.78 |